National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Emergence of Multidrug resistant Tuberculosis (MDRTB) has become a significant obstacle for Tuberculosis (TB) control. Rifampicin (RIF) resistance is important indicator of MDRTB. Rapid simultaneous detection of Mycobacterium Tuberculosis (MTB) and RIF resistance are very essential for effective disease management. CBNAAT (Cartridge Based Nucliec Acid Amplification Test) also known as Gene Xpert MTB/RIF assay is a novel diagnostic tool for detection of MTB and RIF resistance. To study the usefulness of CBNAAT for rapid detection of MTB and RIF resistance in MDRTB suspected cases. 1201 sputum samples were collected from MDRTB suspected cases including both new cases and previously treated cases. These were processed using Gene Xpert MTB/RIF assay. The results were statistically analyzed. Out of 1201 sputum samples, MTB was detected in 268 (22.31%) samples and RIF resistance was detected in 30 (2.49%) samples. 2 (33.33%) RIF resistant samples were from failures, 14(12.17%) from Smear positive (S+) at diagnosis/retreatment case, 10(12.65%) from follow up S+, 1(0.11%) from HIV presumptive TB case. Combination of mutations ie mutations associated with more than one probe was seen in all the 30 RIF resistant samples. Mutations at 5 different rpoB gene regions are 100% at 518-523, 96.66% at 507-511, 90% at 512-518, 86.66% at 523-529 and 43.33% at 529-533. Gene Xpert MTB/RIF assay is a good screening tool for diagnosis of MTB and detection of RIF resistance from MDRTB suspected cases within a shorter period.
Citations |
 |
 |
 |
 |
